Three banned substances, one lost bout: India's kurash campaign hit by doping shame at Asian Games

India's kurash campaign at the Asian Games has ended in doping disgrace. Yash Kumar Chauhan, the 24-year-old competing in the men's +90kg category, has been provisionally suspended after an in-competition sample tested positive for not one but three banned substances: metabolites of the anabolic steroid Metandienone, the endurance-enhancing GW1516, and the stimulant Mephentermine. The positive test adds institutional embarrassment to sporting failure. Chauhan had already been eliminated from the competition, losing his round-of-16 bout 0-10 to Tajikistan's Shakarmamad Mirmamadov. All four Indian kurash athletes lost their bouts — Vishal fell 0-5 to Thailand's Kunathip Yea-on in the quarterfinal, while Sangita and Bharti lost in the women's 57kg category. Kurash, the traditional Central Asian jacket wrestling that is Uzbekistan's national sport, has been part of India's Asian Games programme with a six-member squad. The doping violation now taints the entire campaign and raises uncomfortable questions about the support systems around athletes in lesser-funded disciplines, where testing awareness and medical supervision are often thinnest. Metandienone is a classic anabolic steroid; GW1516, originally developed as a potential treatment for metabolic disorders, was abandoned after animal studies linked it to cancer, and the World Anti-Doping Agency has warned athletes repeatedly about its dangers. Mephentermine is a stimulant. The combination suggests not accidental contamination but a deliberate programme — the kind that anti-doping authorities treat as an aggravating circumstance. Chauhan faces a lengthy ban if the B sample confirms the finding. For Indian sport, already celebrating teenage archer Kumkum Mohod's historic gold at the same Games, the contrast could not be starker: one athlete built on broken family savings and a borrowed bow; another undone by a chemist's cocktail.